# Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder

> **NCT01972074** · PHASE3 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 84 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Memantine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01972074
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-17
- **Primary completion:** 2018-05-07
- **Final completion:** 2018-05-07
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01972074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01972074, "Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01972074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*